Enavate Sciences Gp, Llc Stock Trading & 13F Insights

13F Portfolio Filings

  • Most recent 13F
    Q2 2025
  • Location
    new york, NY
  • CIK
    0001953107
  • All SEC filings
Q2 2025
Quarter
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

6

$176.54 M
IMNM, SIONNA THERAPEUTICS INC, ZENAS BIOPHARMA INC, UPSTREAM BIO INC
13F-HR
Aug 14, 2025
000141588925021852

6

$132.72 M
IMNM, ZENAS BIOPHARMA INC, SIONNA THERAPEUTICS INC, CAMP4 THERAPEUTICS CORP
13F-HR
May 15, 2025
000141588925013132

5

$139.24 M
UPSTREAM BIO INC, IMNM, ZENAS BIOPHARMA INC, CAMP4 THERAPEUTICS CORP
13F-HR
Feb 14, 2025
000110465925014094
Enavate Sciences GP, LLC Stock Trades - Enavate Sciences Gp, Llc 13F